构建中国特色的造血干细胞移植体系

Establish the hematopoietic stem cell transplantation system with Chinese characteristics

造血干细胞移植（HSCT）是一种有效的，有时是唯一的根治性治疗某些血液疾病的治疗方法。HSCT已在中国实行了约50年，并在过去的十年中已作出了很大的改进，尤其是在如半相合造血干细胞移植系统、克服复发和移植物抗宿主病的策略等领域。现描述当前的状况，并展望中国HSCT体系的这些新特色。

Hematopoietic stem cell transplantation （HSCT） is an effective and sometimes the only curative therapy for patients with certain hematological diseases. HSCT has been practiced in China for approximately fifty years, and great improvements have been made within the past decade, especially in fields such as haploidentical HSCT system, strategies to overcome relapse and GVHD. This review will describe the current situation and provide a prospective of these novel characteristics of HSCT system in China.